|
|
Article: Vitex Presents Data on the Behavior of West Nile Virus in Blood and INACTINE(TM) PEN110's Ability to Remove it from Red Blood Cells.
- Article from:
- PR Newswire
- Article date:
- November 5, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
First Company to Demonstrate Ability to Kill West Nile Presents New Data that May Assist in Identifying the Best Way to Halt Transmission through Transfusion
V.I. Technologies, Inc. (Vitex) , a biotechnology company dedicated to improving the safety of the transfusion blood supply, delivered a presentation here today that provides additional research on INACTINE(TM) PEN110's demonstrated ability to inactivate West Nile (WN) virus in red blood cells at a public workshop sponsored in part by the Food and Drug Administration (FDA). The Company will also provide new information about West Nile, which shows that the virus exists in all components of the blood, and ...